Long-term predictors of mortality in ICD patients with non-ischaemic cardiac disease: Impact of renal function

Europace

Volumn 10, Issue 9, 2008, Pages 1052-1059

  Schefer, Thomy ^a   Wolber, Thomas ^a,b   Binggeli, Christian ^a   Holzmeister, Johannes ^a   Brunckhorst, Corinna ^a   Duru, Firat ^a,b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Implantable cardioverter defibrillator; Mortality; Non ischaemic heart disease; Renal insufficiency; Sudden cardiac death

Indexed keywords

AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; SOTALOL;

ADULT; AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DEFIBRILLATOR; FEMALE; GLOMERULUS FILTRATION RATE; HEART ATRIUM FIBRILLATION; HEART DEATH; HEART EJECTION FRACTION; HEART PACING; HEART RIGHT VENTRICLE; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE CONDUCTION; HUMAN; INDEPENDENT VARIABLE; ISCHEMIC HEART DISEASE; KIDNEY FAILURE; KIDNEY FUNCTION; LONG TERM CARE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RECURRENT DISEASE; RISK FACTOR; SURVIVAL RATE; UNITED STATES; CARDIOMYOPATHY; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; HEART MUSCLE ISCHEMIA; INCIDENCE; KIDNEY DISEASE; METHODOLOGY; MIDDLE AGED; RISK ASSESSMENT; STATISTICS; SURVIVAL;

ADULT; AGED; AGED, 80 AND OVER; CARDIOMYOPATHIES; COMORBIDITY; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HUMANS; INCIDENCE; KIDNEY DISEASES; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 55249126685     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eun186     Document Type: Article

References (23)

1. Gregoratos G, Cheitlin MD, Conill A, Epstein AE, Fellows C, Ferguson TB Jr et al. ACC/AHA guidelines for implantation of cardiac pacemakers and antiarrhythmia devices: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee on Pacemaker Implantation). J Am Coll Cardiol 1998;31:1175-209.
2. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace 2006;8:746-837.
3. Bansch D, Antz M, Boczor S, Volkmer M, Tebbenjohanns J, Seidl K et al. Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: the Cardiomyopathy Trial (CAT). Circulation 2002;105:1453-8.
4. Kadish A, Dyer A, Daubert JP, Quigg R, Estes NA, Anderson KP et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 2004;350:2151-8.
5. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352:225-37.
6. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999;130:461-70.
7. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002;39:S1-S266.
8. Bundesamt für Statistik. Lebenserwartung in der Schweiz nach Alter, 1981-2006. http://www.bfs.admin.ch/bfs/portal/de/index/themen/01/06/ blank/dos/la-mortalite-en-suisse/tabl02.html (20 December 2007, date last accessed).
9. Parkash R, Stevenson WG, Epstein LM, Maisel WH. Predicting early mortality after implantable defibrillator implantation: a clinical risk score for optimal patient selection. Am Heart J 2006;151:397-403.
10. Sheldon R, Connolly S, Krahn A, Roberts R, Gent M, Gardner M. Identification of patients most likely to benefit from implantable cardioverterdefibrillator therapy: the Canadian Implantable Defibrillator Study. Circulation 2000;101:1660-4.
11. Koplan BA, Epstein LM, Albert CM, Stevenson WG. Survival in octogenarians receiving implantable defibrillators. Am Heart J 2006;152:714-9.
12. Bigger JT Jr. Epidemiological and mechanistic studies of atrial fibrillation as a basis for treatment strategies. Circulation 1998;98:943-5.
13. Stein KM, Euler DE, Mehra R, Seidl K, Slotwiner DJ, Mittal S et al. Do atrial tachyarrhythmias beget ventricular tachyarrhythmias in defibrillator recipients? J Am Coll Cardiol 2002;40:335-40.
14. Iuliano S, Fisher SG, Karasik PE, Fletcher RD, Singh SN. QRS duration and mortality in patients with congestive heart failure. Am Heart J 2002;143:1085-91.
15. Baldasseroni S, Opasich C, Gorini M, Lucci D, Marchionni N, Marini M et al. Left bundle-branch block is associated with increased 1-year sudden and total mortality rate in 5517 outpatients with congestive heart failure: a report from the Italian network on congestive heart failure. Am Heart J 2002;143:398-405.
16. Sharma AD, Rizo-Patron C, Hallstrom AP, O'Neill GP, Rothbart S, Martins JB et al. Percent right ventricular pacing predicts outcomes in the DAVID trial. Heart Rhythm 2005;2:830-4.
17. Chen-Scarabelli C, Scarabelli TM. Chronic renal insufficiency is an independent predictor of mortality in implantable cardioverter-defibrillator recipients. Pacing Clin Electrophysiol 2007;30:371-6.
18. Eckart RE, Gula LJ, Reynolds MR, Shry EA, Maisel WH. Mortality following defibrillator implantation in patients with renal insufficiency. J Cardiovasc Electrophysiol 2006;17:940-3.
19. Bruch C, Bruch C, Sindermann J, Breithardt G, Gradaus R. Prevalence and prognostic impact of comorbidities in heart failure patients with implantable cardioverter defibrillator. Europace 2007;9:681-6.
20. Henry RM, Kostense PJ, Bos G, Dekker JM, Nijpels G, Heine RJ et al. Mild renal insufficiency is associated with increased cardiovascular mortality: the Hoorn Study. Kidney Int 2002;62:1402-7.
21. Wase A, Basit A, Nazir R, Jamal A, Shah S, Khan T et al. Impact of chronic kidney disease upon survival among implantable cardioverterdefibrillator recipients. J Interv Card Electrophysiol 2004;11:199-204.
22. Converse RL Jr, Jacobsen TN, Toto RD, Jost CM, Cosentino F, Fouad-Tarazi F et al. Sympathetic overactivity in patients with chronic renal failure. N Engl J Med 1992;327:1912-8.
23. Epstein AE, Ellenbogen KA, Kirk KA, Kay GN, Dailey SM, Plumb VJ. Clinical characteristics and outcome of patients with high defibrillation thresholds. A multicenter study. Circulation 1992;86:1206-16.